Pfizer Ltd.

PFIZER

₹5243.35

-0.79% (-41.8)

Market Cap

₹23,973 Cr.

P/E

43.48

About

Pfizer Limited is a pharmaceutical company involved in the manufacturing, marketing, trading, and export of pharmaceutical products. It operates with its own manufacturing facility in Goa and has part… Read more

Pfizer Limited is a pharmaceutical company involved in the manufacturing, marketing, trading, … Read more

Low

3800

52W Range

High

5385

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

19.45%

3yr Average

20.54%

5yr Average

18.17%

Net Profit Margin

Latest

25.73%

3yr Average

23.81%

5yr Average

23.14%

ROCE

Latest

24.79%

3yr Average

26.17%

5yr Average

23.74%

Debt to Equity

Latest

0.0

3yr Average

0.0

5yr Average

0.0

Market Share

17 %

(as of Mar 23)

Source/Historic

Antacid (Gelucil) - Market Share

0 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

2.98 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.14 %

(as of May 19)

Historic

Anti-Malarial - Market Share

67 %

(as of Mar 23)

Source/Historic

Anticholinergics ( Pacitane) - Market Share

2.34 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

75.10 %

(as of Mar 21)

Source/Historic

Becosules - Market Share

6.08 %

(as of Nov 21)

Historic

Blood Related - Market Share

1.88 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

39 %

(as of Mar 19)

Source/Historic

Cefoperazone Sulbactam - Market Share

15.30 %

(as of Mar 23)

Source/Historic

Corex Dx - Market Share

0.05 %

(as of Nov 21)

Historic

Dermatology - Market Share

29.70 %

(as of Mar 22)

Source/Historic

Eliquis - Market Share

30 %

(as of Mar 19)

Source/Historic

Enbrel - Market Share

11.34 %

(as of Nov 21)

Historic

Endocrinology - Market Share

7.50 %

(as of Mar 19)

Source/Historic

Folvite - Market Share

1.82 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

4.45 %

(as of Nov 21)

Historic

Gynecology - Market Share

45 %

(as of Mar 23)

Source/Historic

Hypertension (Minipress) - Market Share

1 %

(as of Mar 19)

Source/Historic

Lyrica - Market Share

6.70 %

(as of Mar 23)

Source/Historic

Magnex - Market Share

5.50 %

(as of Mar 23)

Source/Historic

Meronem - Market Share

2.72 %

(as of Nov 21)

Historic

Neurological - Market Share

1.15 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

1.78 %

(as of Nov 21)

Historic

Pain - Market Share

1.70 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

1.87 %

(as of Nov 21)

Historic

Respiratory - Market Share

1.96 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

0.01 %

(as of Nov 21)

Historic

Stomatological - Market Share

2.40 %

(as of Nov 21)

Historic

Urology - Market Share

3.58 %

(as of Jul 22)

Historic

Vaccines - Market Share

2.66 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source

Peer Comparison

Brands

Autrin

Becosules

Corex Dx

Gelusil

Ovral L

Suppliers

Tata Communications Ltd.
Aarti Industries Ltd.
Piramal Enterprises Ltd.
AGI Greenpac Ltd.
Aarti Drugs Ltd.
Suven Life Sciences Ltd.
Vidhi Specialty Food Ingredients Ltd.
Snowman Logistics Ltd.
Gulshan Polyols Ltd.
Empire Industries Ltd.
Take Solutions Ltd.
Hindusthan National Glass & Industries Ltd.

Showing 5 of 12

FAQs on Pfizer Ltd. Business

What does Pfizer do?

Pfizer Limited is a pharmaceutical company that manufactures, markets & exports products from its manufacturing facility in Goa, India. They have many product portfolios including therapeutics & vaccines that focus on clearly defined areas.

Who are the competitors of Pfizer?

Pfizer major competitors are Natco Pharma, Alembic Pharma, JB Chem & Pharma, Ajanta Pharma, Astrazeneca Pharma I, Ipca Laboratories, Gland Pharma.
Market Cap of Pfizer is ₹23,973 Crs.
While the median market cap of its peers are ₹29,269 Crs.

Is Pfizer financially stable compared to its peers?

Pfizer seems to be financially stable compared to its peers.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate peers.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Jun Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Jun Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Jun Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec